Investigating the link between abdominal aortic aneurysm and primary lung cancer
Epidemiology of Abdominal Aortic Aneurysm With Concomitant Primary Lung Cancer
This study is trying to see if there's a connection between abdominal aortic aneurysms and lung cancer by looking at the health and habits of 2000-3000 lung cancer patients.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 20 Years to 90 Years |
| Sex | All |
| Sponsor | First Affiliated Hospital of Kunming Medical University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 2 sites (Kunming, Yunnan and 1 other locations) |
| Trial ID | NCT06775821 on ClinicalTrials.gov |
What this trial studies
This observational study aims to explore the prevalence and relationship between abdominal aortic aneurysm (AAA) and primary lung cancer by collecting detailed information from 2000-3000 patients diagnosed with lung cancer. The study will analyze lifestyle habits, medical history, and laboratory indicators to identify risk factors associated with AAA in lung cancer patients. By conducting this multi-center prospective epidemiological investigation, the researchers hope to provide scientific evidence that can guide screening and prevention strategies for AAA in this patient population. The findings are expected to improve the treatment and prognosis of lung cancer patients, enhancing their long-term survival rates.
Who should consider this trial
Good fit: Ideal candidates for this study are patients aged 20-90 who have been diagnosed with primary lung cancer.
Not a fit: Patients who refuse to undergo abdominal aortic imaging screening will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved screening and prevention strategies for abdominal aortic aneurysm in patients with primary lung cancer, potentially enhancing their quality of life and survival rates.
How similar studies have performed: While there is limited data on the exact relationship between AAA and lung cancer, previous studies have suggested a notable prevalence, indicating that this investigation could provide valuable insights into an underexplored area.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients diagnosed with primary lung cancer through clinical or pathological examination Exclusion Criteria: * Patients diagnosed with primary lung cancer who refuse to undergo abdominal aortic imaging screening.
Where this trial is running
Kunming, Yunnan and 1 other locations
- The First Affiliated Hospital of Kunming Medical University — Kunming, Yunnan, China (Recruiting)
- The Third Affiliated Hospital of Kunming Medical University — Kunming, Yunnan, China (Recruiting)
Study contacts
- Principal investigator: Gui-ming Liu, MBBS — The Third Affiliated Hospital of Kunming Medical University
- Study coordinator: Kai-xiong Qing, Ph.D.
- Email: davidqkx@gmail.com
- Phone: 15908855311
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.